Walvax PCV13-TT
PCV13-004
Phase 3 mab active
Quick answer
Walvax PCV13-TT for Pneumococcal Disease, Invasive is a Phase 3 program (mab) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biotech Pharmaceutical Co.,
- Indication
- Pneumococcal Disease, Invasive
- Phase
- Phase 3
- Modality
- mab
- Status
- active